Paul Tudor Jones’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Paul Tudor Jones’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-138,700	Closed	-$3.88M	–	1488
2019 Q3	$3.88M	Buy	+138,700	New	+$2.25M	0.13%	160

Paul Tudor Jones's DOVA Position: Q3 2017 in Review

Paul Tudor Jones sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2017, closing a stake of 31,345 shares — an estimated $699K sold.

Paul Tudor Jones first reported a position in DOVA in Q2 2017 and held it in 1 quarter. The position peaked at $699K in Q2 2017. 39 funds tracked by Wall St. Rank hold DOVA as of Q3 2017.

Paul Tudor Jones reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Paul Tudor Jones sold 31,345 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2017, an estimated $699K.
Paul Tudor Jones first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
Paul Tudor Jones's Dova Pharmaceuticals, Inc. Common Stock position peaked at $699K in Q2 2017.
39 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.